ELANElanco Animal Health Inc
- Earnings Call Transcripts
Elanco Animal Health Third Quarter 2026 Results - ELANCO ANIMAL HEALTH INC
Good day, and welcome to Alanko Animal Health Reports 3rd Quarter 2026 Results. At this time, all participants are on listen-only mode. After the speaker's presentation, there will be a question-and-answer session. To as ...
- Analyst Upgrades
Morgan Stanley Maintains Equal-Weight on Elanco Animal Health, Lowers Price Target to $25
Morgan Stanley analyst Erin Wright maintains Elanco Animal Health with a Equal-Weight and lowers the price target from $26 to $25. ...
- Analyst Upgrades
This Qiagen Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Thursday
Analysts downgraded Qiagen, Alcoa and Dutch Bros, cutting price targets for Qiagen to $52 and Dutch Bros to $46. ...
- PR Newswire
Elanco Animal Health Appoints Jamie Preston as Chief People Officer
Preston brings more than two decades of global HR leadership and workforce innovation experience; Dave Kinard to retire at year-endINDIANAPOLIS, Oct. 22, 2026 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ...
- Analyst Upgrades
This Chipotle Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
Wall Street analysts downgraded Accenture, Braze, Chipotle, SmartFinancial and more, with several price-target cuts. ...
- Analyst Upgrades
This Apple Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
Analysts downgraded Werner, Zoetis, Apple, Heartland Express and Elanco, cutting ratings to Neutral/Hold and lowering price targets. ...
- Analyst Upgrades
Jefferies Downgrades Elanco Animal Health to Hold, Lowers Price Target to $24
Jefferies analyst Keith Devas downgrades Elanco Animal Health from Buy to Hold and lowers the price target from $31 to $24. ...
- Analyst Upgrades
This Urban Outfitters Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Analysts initiated coverage: ELAN Buy/$32, IRTC Overweight/$160, BAND Equal-Weight/$56, HRTG Market Perform, and URBN Buy/$100. ...
- Analyst Upgrades
Goldman Sachs Initiates Coverage On Elanco Animal Health with Buy Rating, Announces Price Target of $32
Goldman Sachs analyst Matt Dellatorre initiates coverage on Elanco Animal Health with a Buy rating and announces Price Target of $32. ...
- PR Newswire
Elanco to Participate in BofA Securities Global Healthcare Conference 2026
Elanco Animal Health Incorporated (NYSE: ELAN) will attend the BofA Securities Global Healthcare Conference 2026 on September 22, 2026. Jeff Simmons, ... ...
- Earnings Call Transcripts
Elanco Animal Health - 1775099 - ELANCO ANIMAL HEALTH INC
Hi, good afternoon, everyone, and welcome to the Morgan Stanley Global Healthcare Conference. I'm Erin Bright, Healthcare Services Analyst at Morgan Stanley. For more important disclosures, please see the Morgan Family R ...
- Earnings Call Transcripts
Elanco Animal Health - 1775099 - ELANCO ANIMAL HEALTH INC
Hi, good afternoon, everyone, and welcome to the Morgan Stanley Global Healthcare Conference. I'm Erin Bright, Healthcare Services Analyst at Morgan Stanley. For more important disclosures, please see the Morgan Family R ...
- PR Newswire
Expanding Tick and Itch Season Supports Momentum in Elanco Innovation, Meeting Pet Owner Demand for Health and Wellness Care
As the calendar turns to fall, Americans expect a seasonal reprieve from ticks and allergies. However, with warming temperatures and expanded pollen... ...
- PR Newswire
Elanco Confirms Date and Conference Call for Third Quarter 2026 Financial Results Announcement
Elanco Animal Health Incorporated (NYSE: ELAN) will announce its third quarter 2026 financial results on Friday, November 6, 2026. Elanco will also... ...
- PR Newswire
Elanco to Participate in Morgan Stanley 24th Annual Global Healthcare Conference
Elanco Animal Health Incorporated (NYSE: ELAN) will attend the Morgan Stanley 24th Annual Global Healthcare Conference on September 15, 2026. Jeff... ...
- PR Newswire
Elanco Scales Biologics Capabilities with Expansion of Kansas Manufacturing Facility
Elanco Animal Health Incorporated (NYSE: ELAN) today announced the on-time completion of a 25,000-square-foot manufacturing expansion of its Elwood,... ...
- PR Newswire
Elanco's CLiK™ Extra (dicyclanil topical suspension) Wound Spray Receives FDA Emergency Use Authorization for Application on or Around Wounds for Prevention of New World Screwworm in Variety of Livestock and Captive and Captured Wildlife Species
Elanco Animal Health Incorporated (NYSE: ELAN) today announced it has received Emergency Use Authorization (EUA) from the U.S. Food and Drug... ...
- Analyst Upgrades
UBS Maintains Buy on Elanco Animal Health, Raises Price Target to $33
UBS analyst Andrea Alfonso maintains Elanco Animal Health with a Buy and raises the price target from $31 to $33. ...
- Analyst Upgrades
Keybanc Maintains Overweight on Elanco Animal Health, Raises Price Target to $30
Keybanc analyst Steve Dechert maintains Elanco Animal Health with a Overweight and raises the price target from $29 to $30. ...
- Earnings Call Transcripts
ELANCO ANIMAL HEALTH REPORTS SECOND QUARTER 2026 RESULTS - ELANCO ANIMAL HEALTH INC
Good day and thank you for standing by. Welcome to the Atlanta Animal Health Report's second quarter 2026 results conference call. At this time, all participants are in a listen-only mode. After the speaker's presentatio ...
- PR Newswire
Elanco Animal Health Reports Second Quarter 2026 Results
Elanco Animal Health Incorporated (NYSE: ELAN) today reported financial results for the second quarter of 2026, provided guidance for the third... ...
- PR Newswire
Elanco Releases 2025 Impact Report, Demonstrating How Animal Health Helps Meet Society's Growing Needs
Elanco Animal Health Incorporated (NYSE: ELAN) today released its 2025 Impact Report, "Leading with Purpose," highlighting how the company brings... ...
- Analyst Upgrades
Morgan Stanley Maintains Equal-Weight on Elanco Animal Health, Raises Price Target to $26
Morgan Stanley analyst Erin Wright maintains Elanco Animal Health with a Equal-Weight and raises the price target from $23 to $26. ...
- PR Newswire
Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) Kills Ticks¹ Faster² than Simparica Trio® (sarolaner, moxidectin, and pyrantel chewable tablets) and NexGard® Plus (afoxolaner, moxidectin, and pyrantel chewable tablets)
When it comes to killing ticks, veterinarians and pet owners want it done fast. New data published in Parasites & Vectors, a leading peer-reviewed... ...
- CNBC
Fat cat? Weight-loss drugs may be coming for your overweight pet
Startups are testing GLP-1 treatments for overweight cats while pet-food giants are leaning into longevity products as owners spend more on animal health. ...